In such patients, chronic reductions in calcitriol synthesis, phosphate retention, and reduced sensitivity of calcium-sensing receptors often lead to elevated baseline PTH levels that are not fully suppressed, even in the face of acute hypercalcemia. The gene discussed is PTH; the disease is hypercalcemia disease.